Your session is about to expire
← Back to Search
ION904 for High Blood Pressure
Study Summary
This trial will test a new drug for hypertension (high blood pressure). It will see if the drug lowers AGT levels in the blood.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can new participants sign up for this experiment?
"According to the listing on clinicaltrials.gov, this trial is not presently enrolling patients. This particular study was first announced on April 26th, 2022 and has since been updated on August 31st, 2022. Although this research is not taking any new participants at the moment, there are 785 other trials that are currently recruiting individuals."
Are there any age restrictions for participants in this trial?
"The age range for this trial is between 18 and 75. There are 56 other trials available to people under the legal age of consent and 694 different studies for patients over 65."
Are there other research facilities in the state conducting this investigation?
"There are 11 enrolling sites for this study, which are listed below. - National Research Institute in Los Angeles, California - Progressive Medical Research in Port Orange, Kansas - Altasciences in Overland Park, New york"
How can I sign up to take part in this research project?
"This clinical trial has 48 available spots for patients that fit the following profile: hypertensive, between 18-75 years old, history of uncontrolled hypertension despite medication, no changes to antihypertensive regimen in the 4 weeks before screening, BMI ≤ 45.0 kg/m^2, and must be able to maintain study requirements throughout the treatment period. Males must either be surgically sterile or abstinent; if they are sexually active with a woman of childbearing potential, she must use an effective method of contraception."
What is ION904's standing with the FDA?
"ION904 is still in Phase 2 clinical trials, so there is not yet sufficient data to confirm its efficacy. However, the safety profile of ION904 appears promising as it has cleared multiple rounds of testing."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger